Background: A meta-analysis was conducted to investigate the diagnostic performance of computed tomography (CT) imaging features of ground-glass opacity (GGO) to predict invasiveness. Methods: Two reviewers independently searched PubMed, Medline, Web of Science, Cochrane Embase and CNKI for relevant studies. CT imaging signs of bubble lucency, speculation, lobulated margin, and pleural indentation were used as diagnostic references to discriminate pre-invasive and invasive disease. The sensitivity, specificity, diagnostic odds ratio (DOR), summary receiver operating characteristic (SROC) curves, and the area under the SROC curve (AUC) were calculated to evaluate diagnostic efficiency. Results: Twelve studies were finally included. Diagnostic performance ranged from 0.41 to 0.52 for sensitivity and 0.56 to 0.63 for specificity. The diagnostic positive and negative likelihood ratios ranged from 1.03 to 2.13 and 0.52 to 1.05, respectively. The DORs of the GGO CT features for discriminating invasive disease ranged from 1.02 to 4.00. The area under the ROC curve was also low, with a range of 0.60 to 0.67 for discriminating pre-invasive and invasive disease.
Introduction
Lung cancer is the most commonly diagnosed malignant cancer and one of the leading causes of cancer-related death globally. 1 Epidemiology studies have revealed that although squamous cell carcinoma was initially the most common pathological subtype, adenocarcinoma has now become the dominant subtype. 2 In 2011, the International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS) jointly published a new lung adenocarcinoma classification system. Bronchioloalveolar carcinoma was abandoned and the concept of minimally invasive adenocarcinoma was first introduced. Generally, pre-invasive ground-glass opacity (GGO) was included as atypical adenomatous hyperplasia (AAH) and adenocarcinoma in situ (AIS). Minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma were categorized as invasive disease. It is believed that the change from AAH to MIA is a continuous process. The five-year survival rate has been reported at almost 100% for AAH, AIS, and MIA patients; 3 however, the long-term survival rate of patients with invasive adenocarcinoma remains poor. Therefore, early diagnosis of invasive adenocarcinoma and distinguishing between pre-invasive and invasive lesions is important for the clinical management of GGO.
Clinically, high resolution CT (HRCT) examination is routinely performed to assess GGO lesions. 4 Several imaging features, such as bubble lucency, speculation, lobulated margin, and pleural indentation, were commonly used to predict pathology type. However, the discrimination power of HRCT imaging features to discern pre-invasive from invasive lesions is unclear. Therefore, we evaluated the diagnostic performance of CT imaging features of GGO to predict invasiveness.
Methods

Electronic publication search
Two reviewers independently searched PubMed, Medline, Web of Science, Cochrane Embase, and CNKI for relevant studies. The search terms included: computed tomography, ground-glass nodule, ground-glass opacity, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma. References of the included studies were also screened to locate additional relevant publications.
Inclusion and exclusion criteria
The inclusion criteria were: (i) studies related to CT imaging features to predict invasive and pre-invasive disease; (ii) pathology or cytology examinations were used as the gold standard of diagnosis; and (iii) adequate data could be extracted from the original publication. Exclusion criteria: (i) duplicate publications or data; (ii) case reports or reviews; (iii) the original study did not provide a diagnostic gold standard; (iv) publication in languages other than English or Chinese; and (v) insufficient data available in the original publication.
Data extraction
Two reviewers independently reviewed the full text of each included study. Disagreement was resolved by discussion or consultation with a third reviewer. The first and corresponding author names, publication year and journal, the country in which the study was performed, GGO type, and sample size, were extracted. The number of GGO lesions located using CT imaging signs of bubble lucency, speculation, lobulated margin, and pleural indentation in pre-invasive and invasive GGO were also extracted. All data were cross-checked.
Statistical analysis
Diagnostic sensitivity and specificity were calculated using the formulas: sensitivity = true positive/(true positive + false negative); and specificity = true negative/(true negative + false positive). The area under the receiver operating characteristic (ROC) curve was used to evaluate the feasibility of CT 
Results
General features of the included studies
Initially, 1128 publications were identified; however, after applying the inclusion criteria, twelve studies were finally included in the meta-analysis (Fig 1) . [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The characteristics of the included studies are shown in Table 1 .
Pooled diagnostic sensitivity and specificity
The diagnostic sensitivity and specificity using bubble lucency as a reference of invasive GGO discrimination was 0.52 (0.47-0.57) and 0.63 (0.58-0.67) respectively; For speculation, lobulated margin, and pleural indentation, the (Table 2 ).
Positive and negative likelihood and diagnostic odds ratios
The positive and negative likelihood ratios were 1.36 (1.20-1.54) and 0.79 (0.69-0.90) for bubble lucency; 1.57 (1.16-2.13) and 0.71 (0.52-0.95) for speculation; 1.44 (1.12-1.84) and 0.80 (0.64-1.01) for lobulated margin; and 1.45 (1.03-2.05) and 0.88(0.73-1.05) for pleural indentation, respectively ( Table 3 ). The diagnostic odds ratios for bubble lucency, speculation, lobulated margin, and pleural indentation for discriminating invasive disease were 2.27 (1.59-3.24), 2.96 (1.54-5.67), 2.27 (1.29-4.00), and 1.90 (1.02-3.55), respectively.
Pooled receiver operating characteristic curves
The pooled ROC curve was drawn by sensitivity against 1-specificity using Stata version 12.0. The area under the CT, computed tomography; GGO, ground-glass opacity. ROC curve (AUC) values were 0.64, 0.67, 0.64, and 0.60 for bubble lucency, speculation, lobulated margin, and pleural indentation of GGO for discriminating pre-invasive and invasive disease, respectively (Fig 2) .
Publication analysis
Publication bias of GGO features in CT imaging to predict invasiveness was assessed by Deeks' funnel plot and Egger's line regression test (Fig 3) . No significant bias for bubble lucency (P = 0.36), speculation (P = 0.27), lobulated margin (P = 0.92), or pleural indentation (P = 0.78) was observed (Table 4) .
Discussion
Early stage lung adenocarcinoma is mainly expressed as GGO on HRCT. GGO is a non-specific finding on CT Figure 2 Pooled receiver operating characteristic (ROC) curves for computed tomography imaging signs to discriminate pre-invasive and invasive disease: (a) bubble lucency ( ) study estimate, ( ) Summary point, ( ) HSROC curve, ( ) 95% confidence region, and ( ) 95% prediction region; (b) speculation ( ) study estimate, ( ) Summary point, ( ) HSROC curve, ( ) 95% confidence region, and ( ) 95% prediction region; (c) lobulated margin ( ) study estimate, ( ) Summary point, ( ) HSROC curve, ( ) 95% confidence region, and ( ) 95% prediction region; and (d) pleural indentation ( ) study estimate, ( ) Summary point, ( ) HSROC curve, ( ) 95% confidence region, and ( ) 95% prediction region. HSROC, hierarchical summary receiver operating characteristic.
Thoracic Cancer 9 (2018) 452-458 17 According to its composition, GGO is generally divided into pure GGO (pGGO) or mixed GGO (mGGO). It has been reported that about 18% of pGGO and 63% of mGGO can develop into malignant lesions. 18 Sukki et al. found that about 59% of stable pGGOs developed into AIS or MIA. 19 Studies have proven that the process from AAH to invasive adenocarcinoma is continuous and may take many years.
With developments in CT examination technology, such as the application of low-dose mass screening and HRCT, GGO is now more commonly detected clinically. 20, 21 The five-year survival rate has been reported at almost 100% for AAH, AIS, and MIA patients; 3 however, the long-term survival rate of patients with invasive adenocarcinoma remains poor. [22] [23] [24] Intensive follow-up and CT scan examinations increase the cost of medical care and cause unnecessary patient concern. Thus, how to identify benign and malignant and pre-invasive and invasive lesions remains a challenge for clinicians and radiologists.
Previous studies have evaluated the diagnostic performance of CT imaging features of GGO for discriminating pre-invasive and invasive lesions; however, the results have been inconsistent or inconclusive. 5, 10, 11 In the present study, we examined the results of previous studies of GGO CT imaging features and found low differential diagnostic performance, ranging from 0.41 to 0.52 for sensitivity and 0.56 to 0.63 for specificity. The AUC was also low, with a range of 0.60 to 0.67. These results indicate that the diagnostic performance of a single CT imaging sign for GGO is limited for discriminating pre-invasive and invasive disease because of low sensitivity, specificity, and AUC.
There are some limitations to the present meta-analysis: (i) the general quality of the included studies was relatively poor; (ii) only studies published in English or Chinese were included; and (iii) pooled combined CT imaging features, such as speculation, lobulated margin, and pleural indentation, were not calculated.
Our results indicate that a single CT imaging feature is inadequate to discriminate pre-invasive from invasive disease in cases of GGO. A quantitative diagnostic mathematical model combining CT imagining features is needed to reevaluate diagnostic performance.
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